A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Incyte Corporation
Sun Yat-sen University
Centre Leon Berard
GlaxoSmithKline
J-Pharma Co., Ltd.
Shanghai Zhongshan Hospital
Azienda Ospedaliera Universitaria Integrata Verona
Seoul National University Hospital
Fudan University
Sixth Affiliated Hospital, Sun Yat-sen University
Sixth Affiliated Hospital, Sun Yat-sen University
Sun Yat-sen University
Catharina Ziekenhuis Eindhoven
Sun Yat-sen University
Tanta University